Access 2.8M+ Filings Sign Up Free
Biofrontera AG Logo

Biofrontera AG | B8F - Profile, Filings, Stock Info & Investor Relations Data

Biofrontera AG | B8F
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Germany
Founded
1997
Biofrontera AG (B8F)

Company Profile

Website
Investor Relations

About Biofrontera AG

Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics.The Germany-based company, with almost 200 employees worldwide, develops and markets innovative products for the care, protection and treatment of the skin.
The company's lead product is the combination of Ameluz;, a topical prescription drug, and medical device BF-RhodoLED; for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz; has been marketed in the EU since 2012 and in the United States since May 2016.
Biofrontera is the first German founder-led pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 by the current CEO Prof. Dr. Hermann Luebbert and is listed on the Frankfurt Stock Exchange (Prime Standard) and on the US NASDAQ.

Employees

149

Market Presence

Worldwide

Headquarters

Hemmelrather Weg 201
51377, Leverkusen
Germany

Company Video

Video thumbnail
Click to load video from YouTube

Biofrontera AG (B8F)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Biofrontera AG (B8F)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 7,366.00 EUR 1.27 24.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 381.00 EUR 1.27 24.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 7,503.16 EUR 1.27 20.03.23
↑
NEON Equity AG (Close relation)
Buy EUR 30,627.00 EUR 26.96 13.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 6,290.31 EUR 1.27 13.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 635.00 EUR 1.27 13.03.23
↑
TO Holding 1 GmbH (Close relation)
Buy EUR 575.00 EUR 11.50 13.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 6,718.30 EUR 1.27 10.03.23
↑
Adenauer, Dr. Sven-Georg (Other)
Buy EUR 140,000.00 EUR 140.00 08.03.23
↑
Deutsche Balaton Aktiengesellschaft (Close relation)
Buy EUR 152.40 EUR 1.27 06.03.23

Biofrontera AG (B8F)
Stock & Investor Information

ISINs

DE000A409625
DE000A4BGGM7
US09075G1058

LEI

391200D6GFSVFGFQTL13

Designated Sponsor

ICF Bank AG

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology